Shenyang Xingqi Pharmaceutical Co.,Ltd (300573.SZ)
CNY 70.5
(0.66%)
CNY 70.5
(0.66%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 858.98 Million CNY | 12.32% |
| 2022 | 737.16 Million CNY | 33.38% |
| 2021 | 552.66 Million CNY | 42.56% |
| 2020 | 387.67 Million CNY | 10.62% |
| 2019 | 350.46 Million CNY | 18.97% |
| 2018 | 294.59 Million CNY | 36.92% |
| 2017 | 215.15 Million CNY | 9.53% |
| 2016 | 196.44 Million CNY | 18.11% |
| 2015 | 166.32 Million CNY | 4.56% |
| 2014 | 159.06 Million CNY | 17.12% |
| 2013 | 135.81 Million CNY | -1.0% |
| 2012 | 137.19 Million CNY | 8.19% |
| 2011 | 126.81 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 223.82 Million CNY | 7.03% |
| 2024 Q2 | 261.12 Million CNY | 16.66% |
| 2024 Q3 | 288.88 Million CNY | 10.11% |
| 2023 Q2 | 228.2 Million CNY | 19.9% |
| 2023 Q1 | 190.33 Million CNY | 4.09% |
| 2023 FY | 827.98 Million CNY | 12.32% |
| 2023 Q3 | 224.61 Million CNY | -1.57% |
| 2023 Q4 | 209.12 Million CNY | -6.9% |
| 2022 FY | 737.16 Million CNY | 33.38% |
| 2022 Q2 | 172.74 Million CNY | 11.22% |
| 2022 Q1 | 155.32 Million CNY | 5.17% |
| 2022 Q4 | 182.84 Million CNY | -19.18% |
| 2022 Q3 | 226.23 Million CNY | 30.96% |
| 2021 FY | 552.66 Million CNY | 42.56% |
| 2021 Q2 | 133.02 Million CNY | 14.51% |
| 2021 Q3 | 155.78 Million CNY | 17.11% |
| 2021 Q4 | 147.68 Million CNY | -5.2% |
| 2021 Q1 | 116.17 Million CNY | -3.03% |
| 2020 Q4 | 119.8 Million CNY | -0.76% |
| 2020 Q3 | 120.71 Million CNY | 49.37% |
| 2020 FY | 387.67 Million CNY | 10.62% |
| 2020 Q2 | 80.81 Million CNY | 21.84% |
| 2020 Q1 | 66.33 Million CNY | -22.91% |
| 2019 Q4 | 86.04 Million CNY | -5.94% |
| 2019 Q2 | 93.17 Million CNY | 16.81% |
| 2019 Q1 | 79.76 Million CNY | 11.49% |
| 2019 FY | 350.46 Million CNY | 18.97% |
| 2019 Q3 | 91.47 Million CNY | -1.82% |
| 2018 Q3 | 81.07 Million CNY | 2.13% |
| 2018 FY | 294.59 Million CNY | 36.92% |
| 2018 Q4 | 71.54 Million CNY | -11.76% |
| 2018 Q2 | 79.39 Million CNY | 26.88% |
| 2018 Q1 | 62.57 Million CNY | 9.53% |
| 2017 FY | 215.15 Million CNY | 9.53% |
| 2017 Q4 | 57.12 Million CNY | 1.74% |
| 2017 Q2 | 45.12 Million CNY | -20.5% |
| 2017 Q1 | 56.75 Million CNY | 8.62% |
| 2017 Q3 | 56.15 Million CNY | 24.44% |
| 2016 FY | 196.44 Million CNY | 18.11% |
| 2016 Q1 | 44.17 Million CNY | 0.0% |
| 2016 Q2 | 40.88 Million CNY | -7.45% |
| 2016 Q3 | 59.13 Million CNY | 44.63% |
| 2016 Q4 | 52.25 Million CNY | -11.63% |
| 2015 FY | 166.32 Million CNY | 4.56% |
| 2014 FY | 159.06 Million CNY | 17.12% |
| 2014 Q4 | 45.63 Million CNY | 0.0% |
| 2013 FY | 135.81 Million CNY | -1.0% |
| 2012 FY | 137.19 Million CNY | 8.19% |
| 2011 FY | 126.81 Million CNY | 0.0% |